Review questions sustained efficacy of esketamine in treatment‐resistant depression

Results of a systematic review and meta‐analysis suggest that esketamine has only modest efficacy in the treatment of adults with treatment‐resistant depression, with initial improvement diminishing after the first few days. The results also suggest no effect of esketamine on suicidality.

Publication Details

Journal
The Brown University Psychopharmacology Update
Published
2025-04-29
DOI
https://doi.org/10.1002/pu.31310
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Review questions sustained efficacy of esketamine in treatment‐resistant depression

The Brown University Psychopharmacology Update
Treatment of Major Depression
article

Review questions sustained efficacy of esketamine in treatment‐resistant depression

article en

Abstract

Results of a systematic review and meta‐analysis suggest that esketamine has only modest efficacy in the treatment of adults with treatment‐resistant depression, with initial improvement diminishing after the first few days. The results also suggest no effect of esketamine on suicidality.

The Brown University Psychopharmacology UpdateVol. 36(6)
Openalex Percentile: Top 89%
Treatment of Major Depression
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Review questions sustained efficacy of esketamine in treatment‐resistant depression · The Brown University Psychopharmacology Update (2025) | TGRS Research Map | TGRS